Seoul National University Hospital
Seoul, 110-744, South Korea
NCT Number: NCT01157884
The graft survival in kidney transplantation has been improving after the introduction of new immunosuppressive agents. Therefore, other complications after transplantation are concerned; one of those is obesity. Several factors are attributable to obesity in kidney transplant recipients.
The body composition such as fat mass and lean mass is important concept in overweight patients. Some studies have been conducted on the change of body composition in kidney transplants. However, all of them are studied among Caucasians or using dual energy X-ray absorptiometry (DEXA).
In this study, the investigators plan to study the body composition among Asian kidney transplant recipients using the bioelectrical impedance analysis (BIA).
Looking for future studies?
Notify Me20 year and older
All sexes
Observational
Seoul, 110-744, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2 weeks, 1/3/6/9/12 months after transplantation
fat mass, lean mass
Time frame: 2 weeks, 1/3/6/9/12 months after transplantation
Time frame: 2 weeks, 1/3/6/9/12 months after transplantation
Looking for future studies?
Notify MeSeoul National University Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00531921
Behavior, Cardiovascular Diseases
Chicago, Illinois, United States
View Trial DetailsNCT00308802
Behavior, Chronic Disease
New Haven, Connecticut, United States
View Trial DetailsNCT00337220
Chronic Disease, Disease Attributes
Chicago, Illinois, United States
View Trial DetailsNCT04910867
Apolipoprotein L1, Chronic Disease
Washington D.C., District of Columbia, United States
View Trial Details